San Francisco, USA

Andrea holds a Master’s in Molecular Biotechnology and is recognized as one of Europe's top 100 young scientists. A seasoned science communicator and co-inventor of OncoSwab's cutting-edge technology, she has also contributed her insights as a panelist at the European Commission in Brussels, advancing the conversation on entrepreneurship globally.

Basel, Switzerland

Dr. Pablo Lara holds a Ph.D. in Pharmacology and brings over a decade of experience in cancer research, across both academia and industry. He has authored numerous peer-reviewed publications, showcasing his dedication to advancing medical science. Dr. Lara also has extensive expertise in product development and licensing, successfully translating research innovations into market-ready solutions.

New York, USA

Dr. Javier Zulueta, Chief of Pulmonary Medicine at Mount Sinai Morningside, is a globally recognized leader in pulmonology and a pioneer in lung cancer screening. He established Europe’s first and longest-running lung cancer screening program, significantly advancing early detection methodologies. Dr. Zulueta's expertise extends to designing clinical trials and overseeing quality assurance and regulatory affairs, ensuring rigorous standards in research and patient care.

Naples, Italy

Roberta Gatta, PhD in Biotechnology and clinical operations specialist at OncoSwab, orchestrates the company's multi-centric clinical trials. Selected as a Women2Invest figure by the European Institute of Innovation and Technology, Roberta combines her profound scientific expertise with strategic investment insights, honed through her experience in healthcare venture capital at EureKARE.

San Francisco, USA

With an MSc in Human Rights from the London School of Economics, Nadja's background in regulatory affairs and international law uniquely positions her to navigate complex regulatory challenges and drive impactful policy integration.